Clinical Trial Update: Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery [Phase 3]

View source ↗

Summary

A multicenter Phase 3 trial evaluated the analgesic efficacy of XP21L for postoperative pain after bunionectomy, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• XP21L

Snippet

Sponsor: Xanodyne Pharmaceuticals | Conditions: Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2010-06-22